Osaka, Japan

Sachiko Oda


Average Co-Inventor Count = 5.5

ph-index = 2

Forward Citations = 60(Granted Patents)


Location History:

  • Osaka, JP (1994)
  • Yao, JP (1998)

Company Filing History:


Years Active: 1994-1998

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Sachiko Oda

Introduction

Sachiko Oda is a prominent inventor based in Osaka, Japan. She has made significant contributions to the field of biotechnology, particularly in cancer research. With a total of two patents to her name, Oda's work focuses on improving methods for culturing animal cells and testing the sensitivity of anticancer drugs.

Latest Patents

Oda's latest patents include a "Method for culturing animal cells in collagen drops on a support" and a "Method for testing the sensitivity of anticancer drug." The latter invention relates to a method of testing the sensitivity of cancer drugs using cancer cells cultured in vitro. In this innovative approach, cancer cells are cultured in a collagen gel substrate, allowing for the proliferation of various human cancer cell types. However, the presence of fibroblast cells can hinder the measurement of cancer cell growth. Oda's invention addresses this issue by utilizing an image processor to selectively extract the image signals of cancer cells and their colonies. This method enables effective results to be obtained within a short period of time.

Career Highlights

Oda is currently employed at Nitta Gelatin Inc., where she continues to advance her research and development efforts. Her work has garnered attention in the scientific community, contributing to the ongoing fight against cancer.

Collaborations

Some of her notable coworkers include Masahiro Koezuka and Naohito Kondo, who collaborate with her on various projects within the company.

Conclusion

Sachiko Oda's innovative work in the field of biotechnology highlights her dedication to improving cancer treatment methods. Her patents reflect her commitment to advancing scientific knowledge and providing solutions that can benefit patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…